Reduction of methotrexate toxicity with improved nutritional status in tumor‐bearing animals

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Cancer

• Publication date

  1988-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0142(19880501)61:9<1731::AID-CNCR2820610902>3.0.CO;2-APMID 3128396
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Albumin standards and the measurement of serum albumin with bromcresol green.

  1997cited by this paper
• The clinical pharmacology of methotrexate.

  1983cited by this paper
• AN EXPERIMENTAL BIOLOGICAL BASIS FOR INCREASING THE THERAPEUTIC INDEX OF CLINICAL CANCER THERAPY

  1982cited by this paper
• Survival response of malignant gliomas to radiotherapy with or without BCNU or methyl-CCNU chemotherapy at the University of Kentucky Medical Center.

  1981cited by this paper
• Clinical pharmacology of methotrexate.

  1981cited by this paper
• A prospective randomized study of adjuvant parenteral nutrition in the treatment of diffuse lymphoma: effect on drug tolerance.

  1981cited by this paper
• Methotrexate cytotoxicity: studies on its reversal by folates and nucleosides.

  1981cited by this paper
• Protein-calorie malnutrition and 5-fluorouracil toxicity.

  1979cited by this paper
• Protein-calorie malnutrition and 5-fluorouracil toxicity.

  1979cited by this paper
• Nutritional support for cancer patients receiving abdominal and pelvic radiotherapy: a randomized prospective clinical experiment of intravenous versus oral feeding.

  1978cited by this paper
• Cell kinetics and chemotherapy: a critical review.

  1978cited by this paper
• Protection against chemotherapy toxicity by IV hyperalimentation.

  1978cited by this paper
• Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity.

  1977cited by this paper
• Effects of methotrexate on cellular metabolism: Some critical elements in the drug cell interaction

  1977cited by this paper
• Effects of methotrexate on cellular metabolism: some critical elements in the drug-cell interaction.

  1977cited by this paper
• The Clinical Pharmacology of Antineoplastic Agents

  1975cited by this paper
• The reversal of methotrexate toxicity by thymidine with maintenance of antitumour effects

  1975cited by this paper
• The clinical pharmacology of antineoplastic agents (second of two parts).

  1975cited by this paper
• Intravenous hyperalimentation as an adjunct to cancer chemotherapy.

  1975cited by this paper
• The clinical pharmacology of antineoplastic agents (first of two parts).

  1975cited by this paper
• Combination versus single agent chemotherapy: A review of the basis for selection of drug treatment of cancer

  1975cited by this paper
• Effects of nutrition on tumor growth and tolerance to chemotherapy.

  1975cited by this paper
• Clinical trials and pharmacokinetics of intermittent high-dose methotrexate-"leucovorin rescue" for children with malignant tumors.

  1974cited by this paper
• Methotrexate therapy of head and neck cancer: improvement in therapeutic index by the use of leucovorin "rescue".

  1970cited by this paper
• EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA.

  1964cited by this paper
• The Principles of Chemotherapy

  1952cited by this paper

• Ce qui ne tue pas rend plus fort : la promesse des restrictions alimentaires ?

  2020cites this paper
• Impact of Undernutrition on the Pharmacokinetics and Pharmacodynamics of Anticancer Drugs: A Literature Review

  2017cites this paper
• A difficult clinical problem: diagnosis, impact and clinical management of cachexia in palliative care.

  2009cites this paper
• Potential Therapeutic lmplications

  2006cites this paper
• Nutritional Supplementation with Transforming Growth Factor-β, Glutamine, and Short Chain Fatty Acids Minimizes Methotrexate-Induced Injury

  2006influential citation
• Pharmaco-Nutritional Supports for the Treatment of Cancer Cachexia

  2006cites this paper
• Protective effects of dietary enrichment with docosahexaenoic acid plus protein in 5-fluorouracil-induced intestinal injury in the rat

  2004cites this paper
• Protection against methotrexate toxicity by a soybean protein- and omega-3 fatty acid-containing diet: comparative study with a casein-containing diet.

  2004cites this paper
• Nutrition au cours des radiothérapies et chimiothérapies

  2001cites this paper
• Growth hormone and colorectal carcinoma: localization of receptors.

  2000cites this paper
• Dietary composition alters methotrexate toxicity without changing its pharmacokinetic parameters in cats

  1997cites this paper
• Negative impact of cancer chemotherapy on protein metabolism in healthy and tumor-bearing rats.

  1995cites this paper
• Metabolic consequences of methotrexate therapy in tumour‐bearing rats

  1994cites this paper
• Effect of protein-calorie malnutrition on methotrexate pharmacokinetics.

  1994cites this paper
• Effect of protein-intake on dihydrofolate-reductase activity of host and tumor-tissues.

  1994cites this paper
• Rethinking nutritional support of the cancer patient: the new field of nutritional oncology.

  1994cites this paper
• Isolation and quantitation of rat hepatic metallothionein after methotrexate administration

  1994cites this paper
• Lethal toxicity of cyclophosphamide depends on the tumor stage. Studies on the syngeneic adenocarcinoma EO 771 in C57bl/6j mice.

  1993cites this paper
• Protein Calorie Malnutrition and Cancer Therapy

  1992cites this paper
• The in vitro and in vivo effects of human growth hormone administration on tumor growth of rats bearing a transplantable rat pituitary tumor (7315b).

  1990cites this paper
• Alteration of methotrexate metabolism in rats by administration of an elemental liquid diet I. Changes in drug enterohepatic circulation

  1987cites this paper
• Nutritional support in the cancer‐bearing host: Effects on host and tumor

  1986cites this paper